Chemical modulation of Kv7 potassium channels
Open accessThe DOI matches its Crossref record; 386 of the 386 references it cites were found in a registry or an index.
Abstract
This review describes the synthetic and medicinal chemistry of small molecule modulators of the voltage-gated Kv7 (KCNQ) potassium channels and the available data of their biological and clinical properties.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Natural-product leads like echinocystic acid and endogenous modulators such as dehydroepiandrosterone sulfate (DHEAS) expand chemotype space and suggest allosteric stabilization strategies that preserve physiological gating [267,269].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [267]
In the citing paper
“Structure-guided chemistry and in silico design have produced Kv7.2/7.3-biased agonists with order-of-magnitude potency gains over retigabine, improved pharmacokinetics, and reduced liabilities linked to earlier chemotypes [265,266,267].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [267]
In the citing paper
“Brain-penetrant exemplars such as Lu AA41178 and SCR2682, pan-Kv7 (KCNQ2–5) potassium-channel activators, demonstrate broad antiexcitability efficacy without major off-target activity, while clinical candidates including azetukalner and BHV-7000, Kv7.2/7.3-selective channel activators, aim to retain efficacy while avoiding pigmentation and urinary liabilities associated with earlier chemotypes [”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [267]
Citations
Cites
Fluorine in medicinal chemistry
Purser, S., Moore, P. R., Swallow, S., & Gouverneur, V. (2008) · Chem. Soc. Rev. · doi:10.1039/b610213c · Cited by 7,570
Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S. W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81369-0 · Cited by 3,073
Ho Kim, S., & Mo Chung, J. (1992) · Pain · doi:10.1016/0304-3959(92)90041-9 · Cited by 3,069
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
Meanwell, N. A. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01788 · Cited by 2,655
Brown, R. H., & Al-Chalabi, A. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1603471 · Cited by 2,125
Colloca, L., Ludman, T., Bouhassira, D., Baron, R., Dickenson, A. H., Yarnitsky, D., Freeman, R., Truini, A., Attal, N., Finnerup, N. B., et al. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.2 · Cited by 2,058
Coassembly of KVLQT1 and minK (IsK) proteins to form cardiac IKS potassium channel
Sanguinetti, M. C., Curran, M. E., Zou, A., Shen, J., Specter, P. S., Atkinson, D. L., & Keating, M. T. (1996) · Nature · doi:10.1038/384080a0 · Cited by 1,764
Alzheimer Mechanisms and Therapeutic Strategies
Huang, Y., & Mucke, L. (2012) · Cell · doi:10.1016/j.cell.2012.02.040 · Cited by 1,758
KvLQT1 and IsK (minK) proteins associate to form the IKS cardiac potassium current
Barhanin, J., Lesage, F., Guillemare, E., Fink, M., Lazdunski, M., & Romey, G. (1996) · Nature · doi:10.1038/384078a0 · Cited by 1,614
Seretny, M., Currie, G. L., Sena, E. S., Ramnarine, S., Grant, R., MacLeod, M. R., Colvin, L. A., & Fallon, M. (2014) · Pain · doi:10.1016/j.pain.2014.09.020 · Cited by 1,555
Molecular identification of a renal urate–anion exchanger that regulates blood urate levels
Enomoto, A., Kimura, H., Chairoungdua, A., Shigeta, Y., Jutabha, P., Ho Cha, S., Hosoyamada, M., Takeda, M., Sekine, T., Igarashi, T., et al. (2002) · Nature · doi:10.1038/nature742 · Cited by 1,535
KCNQ2 and KCNQ3 Potassium Channel Subunits: Molecular Correlates of the M-Channel
Wang, H. (1998) · Science · doi:10.1126/science.282.5395.1890 · Cited by 1,294
Resonance, oscillation and the intrinsic frequency preferences of neurons
Hutcheon, B., & Yarom, Y. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01547-2 · Cited by 1,137
Seizures and Epilepsy: An Overview for Neuroscientists
Stafstrom, C. E., & Carmant, L. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a022426 · Cited by 933
Neyroud, N., Tesson, F., Denjoy, I., Leibovici, M., Donger, C., Barhanin, J., Fauré, S., Gary, F., Coumel, P., Petit, C., et al. (1997) · Nature Genetics · doi:10.1038/ng0297-186 · Cited by 891
Neuronal KCNQ potassium channels:physislogy and role in disease
Jentsch, T. J. (2000) · Nature Reviews Neuroscience · doi:10.1038/35036198 · Cited by 849
Neuropathic pain: mechanisms and their clinical implications
Cohen, S. P., & Mao, J. (2014) · BMJ · doi:10.1136/bmj.f7656 · Cited by 802
Voltage-gated potassium channels as therapeutic targets
Wulff, H., Castle, N. A., & Pardo, L. A. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2983 · Cited by 799
Pathways modulating neural KCNQ/M (Kv7) potassium channels
Delmas, P., & Brown, D. A. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1785 · Cited by 686
Brown, D. A., & Passmore, G. M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00111.x · Cited by 676
Intrinsic Membrane Hyperexcitability of Amyotrophic Lateral Sclerosis Patient-Derived Motor Neurons
Wainger, B. J., Kiskinis, E., Mellin, C., Wiskow, O., Han, S. S. W., Sandoe, J., Perez, N. P., Williams, L. A., Lee, S., Boulting, G., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.03.019 · Cited by 662
Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis
Friese, M. A., Schattling, B., & Fugger, L. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.37 · Cited by 628
Bursts as a unit of neural information: selective communication via resonance
Izhikevich, E. M., Desai, N. S., Walcott, E. C., & Hoppensteadt, F. C. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00034-1 · Cited by 612
Parkinson's disease: Mechanisms, translational models and management strategies
Raza, C., Anjum, R., & Shakeel, N. U. A. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.03.057 · Cited by 603
Pan, Z., Kao, T., Horvath, Z., Lemos, J., Sul, J.-Y., Cranstoun, S. D., Bennett, V., Scherer, S. S., & Cooper, E. C. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4314-05.2006 · Cited by 585
Drug treatments in Alzheimer’s disease
Briggs, R., Kennelly, S. P., & O’Neill, D. (2016) · Clinical Medicine · doi:10.7861/clinmedicine.16-3-247 · Cited by 571
Functional diversity and specificity of neostriatal interneurons
Tepper, J. M., & Bolam, J. P. (2004) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2004.10.003 · Cited by 526
Rapid Chemically Induced Changes of PtdIns(4,5)P 2 Gate KCNQ Ion Channels
Suh, B.-C., Inoue, T., Meyer, T., & Hille, B. (2006) · Science · doi:10.1126/science.1131163 · Cited by 505
Rodent models of streptozotocin‐induced diabetic nephropathy (Methods in Renal Research)
TESCH, G. H., & ALLEN, T. J. (2007) · Nephrology · doi:10.1111/j.1440-1797.2007.00796.x · Cited by 483
Riluzole and edaravone: A tale of two amyotrophic lateral sclerosis drugs
Jaiswal, M. K. (2019) · Medicinal Research Reviews · doi:10.1002/med.21528 · Cited by 451
Cortex, Cognition and the Cell: New Insights into the Pyramidal Neuron and Prefrontal Function
Elston, G. N. (2003) · Cerebral Cortex · doi:10.1093/cercor/bhg093 · Cited by 440
KCNQ potassium channels: physiology, pathophysiology, and pharmacology
Robbins, J. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00116-4 · Cited by 430
Peters, H. C., Hu, H., Pongs, O., Storm, J. F., & Isbrandt, D. (2005) · Nature Neuroscience · doi:10.1038/nn1375 · Cited by 423
Hu, H., Vervaeke, K., & Storm, J. F. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2002.029249 · Cited by 417
Tatulian, L., Delmas, P., Abogadie, F. C., & Brown, D. A. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-15-05535.2001 · Cited by 406
KCNQ5, a Novel Potassium Channel Broadly Expressed in Brain, Mediates M-type Currents
Schroeder, B. C., Hechenberger, M., Weinreich, F., Kubisch, C., & Jentsch, T. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003245200 · Cited by 387
SLC2A9 Is a High-Capacity Urate Transporter in Humans
Caulfield, M. J., Munroe, P. B., O'Neill, D., Witkowska, K., Charchar, F. J., Doblado, M., Evans, S., Eyheramendy, S., Onipinla, A., Howard, P., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050197 · Cited by 378
Gu, N., Vervaeke, K., Hu, H., & Storm, J. F. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2005.086835 · Cited by 363
Marrion, N. V. (1997) · Annual Review of Physiology · doi:10.1146/annurev.physiol.59.1.483 · Cited by 350
9α-FLUORO DERIVATIVES OF CORTISONE AND HYDROCORTISONE
Fried, J., & Sabo, E. F. (1954) · Journal of the American Chemical Society · doi:10.1021/ja01634a101 · Cited by 323
Retigabine, A Novel Anti-Convulsant, Enhances Activation of KCNQ2/Q3 Potassium Channels
Wickenden, A. D., Yu, W., Zou, A., Jegla, T., & Wagoner, P. K. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12425-x · Cited by 320
Gunthorpe, M. J., Large, C. H., & Sankar, R. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2011.03365.x · Cited by 319
Ion Channels as Therapeutic Targets: A Drug Discovery Perspective
Bagal, S. K., Brown, A. D., Cox, P. J., Omoto, K., Owen, R. M., Pryde, D. C., Sidders, B., Skerratt, S. E., Stevens, E. B., Storer, R. I., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm3011433 · Cited by 316
Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels
Gribkoff, V. K., Starrett, J. E., Dworetzky, S. I., Hewawasam, P., Boissard, C. G., Cook, D. A., Frantz, S. W., Heman, K., Hibbard, J. R., Huston, K., et al. (2001) · Nature Medicine · doi:10.1038/86546 · Cited by 311
Cooper, E. C., Harrington, E., Jan, Y. N., & Jan, L. Y. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-24-09529.2001 · Cited by 305
Functional significance of axonal Kv7 channels in hippocampal pyramidal neurons
Shah, M. M., Migliore, M., Valencia, I., Cooper, E. C., & Brown, D. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802805105 · Cited by 299
Liu, B., Linley, J. E., Du, X., Zhang, X., Ooi, L., Zhang, H., & Gamper, N. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41084 · Cited by 289
VDAC1, mitochondrial dysfunction, and Alzheimer’s disease
Shoshan-Barmatz, V., Nahon-Crystal, E., Shteinfer-Kuzmine, A., & Gupta, R. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.03.010 · Cited by 286
Advances in understanding nociception and neuropathic pain
St. John Smith, E. (2018) · Journal of Neurology · doi:10.1007/s00415-017-8641-6 · Cited by 282
An Overview of Neuropathic Pain: Syndromes, Symptoms, Signs, and Several Mechanisms
Dworkin, R. H. (2002) · The Clinical Journal of Pain · doi:10.1097/00002508-200211000-00001 · Cited by 277
Increased anterior cingulate and caudate activity in bipolar mania
Blumberg, H. P., Stern, E., Martinez, D., Ricketts, S., de Asis, J., White, T., Epstein, J., McBride, P. A., Eidelberg, D., Kocsis, J. H., et al. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00962-8 · Cited by 277
Lerche, C., Scherer, C. R., Seebohm, G., Derst, C., Wei, A. D., Busch, A. E., & Steinmeyer, K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002378200 · Cited by 277
Ryckmans, T., Edwards, M. P., Horne, V. A., Correia, A. M., Owen, D. R., Thompson, L. R., Tran, I., Tutt, M. F., & Young, T. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.05.062 · Cited by 270
Underlying Mechanisms of Tinnitus: Review and Clinical Implications
Henry, J. A., Roberts, L. E., Caspary, D. M., Theodoroff, S. M., & Salvi, R. J. (2014) · Journal of the American Academy of Audiology · doi:10.3766/jaaa.25.1.2 · Cited by 268
Regulation of Kv7 (KCNQ) K + Channel Open Probability by Phosphatidylinositol 4,5-Bisphosphate
Li, Y., Gamper, N., Hilgemann, D. W., & Shapiro, M. S. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2597-05.2005 · Cited by 265
Wuttke, T. V., Seebohm, G., Bail, S., Maljevic, S., & Lerche, H. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.010793 · Cited by 262
Effects of obesity on depression: A role for inflammation and the gut microbiota
Schachter, J., Martel, J., Lin, C.-S., Chang, C.-J., Wu, T.-R., Lu, C.-C., Ko, Y.-F., Lai, H.-C., Ojcius, D. M., & Young, J. D. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.08.026 · Cited by 253
Pribiag, H., & Stellwagen, D. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.0530-13.2013 · Cited by 247
AKAP150 signaling complex promotes suppression of the M-current by muscarinic agonists
Hoshi, N., Zhang, J.-S., Omaki, M., Takeuchi, T., Yokoyama, S., Wanaverbecq, N., Langeberg, L. K., Yoneda, Y., Scott, J. D., Brown, D. A., et al. (2003) · Nature Neuroscience · doi:10.1038/nn1062 · Cited by 244
Metabolic crisis occurs with seizures and periodic discharges after brain trauma
Vespa, P., Tubi, M., Claassen, J., Buitrago‐Blanco, M., McArthur, D., Velazquez, A. G., Tu, B., Prins, M., & Nuwer, M. (2016) · Annals of Neurology · doi:10.1002/ana.24606 · Cited by 242
KCNQ channels mediate IKs, a slow K+ current regulating excitability in the rat node of Ranvier
Schwarz, J. R., Glassmeier, G., Cooper, E. C., Kao, T. ‐., Nodera, H., Tabuena, D., Kaji, R., & Bostock, H. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.106815 · Cited by 236
Ion channels and signaling in the pituitary gland
Stojilkovic, S. S., Tabak, J., & Bertram, R. (2010) · Endocrine Reviews · doi:10.1210/er.2010-0005 · Cited by 229
Bosch, R. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00021-2 · Cited by 225
BMS‐204352: A Potassium Channel Opener Developed for the Treatment of Stroke
Jensen, B. S. (2002) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2002.tb00233.x · Cited by 223
Calmodulin Mediates Ca2+-dependent Modulation of M-type K+ Channels
Gamper, N., & Shapiro, M. S. (2003) · The Journal of General Physiology · doi:10.1085/jgp.200208783 · Cited by 222
Peretz, A., Degani, N., Nachman, R., Uziyel, Y., Gibor, G., Shabat, D., & Attali, B. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.007112 · Cited by 218
Hyperpolarization‐activated cation channels in fast‐spiking interneurons of rat hippocampus
Aponte, Y., Lien, C., Reisinger, E., & Jonas, P. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2005.104042 · Cited by 213
Channelopathies of Skeletal Muscle Excitability
Cannon, S. C. (2015) · Comprehensive Physiology · doi:10.1002/cphy.c140062 · Cited by 212
Yarov-Yarovoy, V., Baker, D., & Catterall, W. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602350103 · Cited by 211
Blackburn-Munro, G., & Jensen, B. S. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02924-2 · Cited by 208
Central Proinflammatory Cytokines and Pain Enhancement
Wieseler-Frank, J., Maier, S. F., & Watkins, L. R. (2005) · Neurosignals · doi:10.1159/000087655 · Cited by 198
International Guidelines for the Treatment of Huntington's Disease
Bachoud-Lévi, A.-C., Ferreira, J., Massart, R., Youssov, K., Rosser, A., Busse, M., Craufurd, D., Reilmann, R., De Michele, G., Rae, D., et al. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00710 · Cited by 193
Battefeld, A., Tran, B. T., Gavrilis, J., Cooper, E. C., & Kole, M. H. P. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.4206-13.2014 · Cited by 180
Modulation of Kv7 channels and excitability in the brain
Greene, D. L., & Hoshi, N. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2359-y · Cited by 177
Martire, M., Castaldo, P., D'Amico, M., Preziosi, P., Annunziato, L., & Taglialatela, M. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3143-03.2004 · Cited by 175
Hu, H., Vervaeke, K., & Storm, J. F. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4463-06.2007 · Cited by 172
KCNQ channel openers reverse depressive symptoms via an active resilience mechanism
Friedman, A. K., Juarez, B., Ku, S. M., Zhang, H., Calizo, R. C., Walsh, J. J., Chaudhury, D., Zhang, S., Hawkins, A., Dietz, D. M., et al. (2016) · Nature Communications · doi:10.1038/ncomms11671 · Cited by 172
Winks, J. S., Hughes, S., Filippov, A. K., Tatulian, L., Abogadie, F. C., Brown, D. A., & Marsh, S. J. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3231-04.2005 · Cited by 170
Lupica, C. R., Bell, J. A., Hoffman, A. F., & Watson, P. L. (2001) · Journal of Neurophysiology · doi:10.1152/jn.2001.86.1.261 · Cited by 170
Vergo, S., Craner, M. J., Etzensperger, R., Attfield, K., Friese, M. A., Newcombe, J., Esiri, M., & Fugger, L. (2011) · Brain · doi:10.1093/brain/awq337 · Cited by 168
Zilliox, L. A. (2017) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000462 · Cited by 168
Driving With No Brakes: Molecular Pathophysiology of Kv7 Potassium Channels
Soldovieri, M. V., Miceli, F., & Taglialatela, M. (2011) · Physiology · doi:10.1152/physiol.00009.2011 · Cited by 164
Structural Insight into KCNQ (Kv7) Channel Assembly and Channelopathy
Howard, R. J., Clark, K. A., Holton, J. M., & Minor, D. L. (2007) · Neuron · doi:10.1016/j.neuron.2007.02.010 · Cited by 164
A Novel Benzodiazepine that Activates Cardiac Slow Delayed Rectifier K+ Currents
Salata, J. J., Jurkiewicz, N. K., Wang, J., Evans, B. E., Orme, H. T., & Sanguinetti, M. C. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.1.220 · Cited by 158
Benzbromarone in the treatment of gout
Azevedo, V. F., Kos, I. A., Vargas‐Santos, A. B., Pinheiro, G. D. R. C., & Paiva, E. D. S. (2019) · Revista Brasileira de Reumatologia · doi:10.1186/s42358-019-0080-x · Cited by 156
Shah, N. H., & Aizenman, E. (2014) · Translational Stroke Research · doi:10.1007/s12975-013-0297-7 · Cited by 155
Lee, S., Banerjee, A., & MacKinnon, R. (2009) · PLoS Biology · doi:10.1371/journal.pbio.1000047 · Cited by 154
Hansen, R. S., Diness, T. G., Christ, T., Demnitz, J., Ravens, U., Olesen, S., & Grunnet, M. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.015859 · Cited by 145
Cortical and Striatal Circuits in Huntington’s Disease
Blumenstock, S., & Dudanova, I. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00082 · Cited by 143
Molecular basis for ligand activation of the human KCNQ2 channel
Li, X., Zhang, Q., Guo, P., Fu, J., Mei, L., Lv, D., Wang, J., Lai, D., Ye, S., Yang, H., et al. (2020) · Cell Research · doi:10.1038/s41422-020-00410-8 · Cited by 143
Neurodegenerative diseases: From available treatments to prospective herbal therapy
Solanki, I., Parihar, P., & Parihar, M. S. (2015) · Neurochemistry International · doi:10.1016/j.neuint.2015.11.001 · Cited by 143
h channel-dependent deficit of theta oscillation resonance and phase shift in temporal lobe epilepsy
Marcelin, B., Chauvière, L., Becker, A., Migliore, M., Esclapez, M., & Bernard, C. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.11.019 · Cited by 141
Tzingounis, A. V., Heidenreich, M., Kharkovets, T., Spitzmaul, G., Jensen, H. S., Nicoll, R. A., & Jentsch, T. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004644107 · Cited by 141
Anxiolytic Effects of Maxipost (BMS-204352) and Retigabine via Activation of Neuronal Kv7 Channels
Korsgaard, M. P. G., Hartz, B. P., Brown, W. D., Ahring, P. K., Strøbæk, D., & Mirza, N. R. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.083923 · Cited by 141
KCNQ-Encoded Potassium Channels as Therapeutic Targets
Barrese, V., Stott, J. B., & Greenwood, I. A. (2018) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010617-052912 · Cited by 137
Zaczek, R., Chorvat, R. J., Saye, J. A., Pierdomenico, M. E., Maciag, C. M., Logue, A. R., Fisher, B. N., Rominger, D. H., & Earl, R. A. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37471-3 · Cited by 136
Gamper, N., Li, Y., & Shapiro, M. S. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-09-0849 · Cited by 136
A carboxy‐terminal domain determines the subunit specificity of KCNQ K + channel assembly
Schwake, M., Jentsch, T. J., & Friedrich, T. (2003) · EMBO reports · doi:10.1038/sj.embor.embor715 · Cited by 135
The KCNQ1 (Kv7.1) COOH Terminus, a Multitiered Scaffold for Subunit Assembly and Protein Interaction
Wiener, R., Haitin, Y., Shamgar, L., Fernández‐Alonso, M. C., Martos, A., Chomsky-Hecht, O., Rivas, G., Attali, B., & Hirsch, J. A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707541200 · Cited by 134
KCNQ/M‐currents contribute to the resting membrane potential in rat visceral sensory neurons
Wladyka, C. L., & Kunze, D. L. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.113308 · Cited by 134
Chemotherapy-induced neuropathic pain
Farquhar-Smith, P. W. (2010) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0b013e328342f9cc · Cited by 134
Lehman, A., Thouta, S., Mancini, G. M. S., Naidu, S., van Slegtenhorst, M., McWalter, K. M., Person, R., Mwenifumbo, J. C., Salvarinova, R., Guella, I., et al. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.05.016 · Cited by 133
Review of salicylate-induced hearing loss, neurotoxicity, tinnitus and neuropathophysiology.
Sheppard, A., Hayes, S. H., Chen, G.-D., Ralli, M., & Salvi, R. (2014) · PubMed Central · Cited by 132
Wickenden, A. D., Krajewski, J. L., London, B., Wagoner, P. K., Wilson, W. A., Clark, S., Roeloffs, R., McNaughton-Smith, G. A., & Rigdon, G. C. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.043216 · Cited by 129
Wang, H.-S., Brown, B. S., McKinnon, D., & Cohen, I. S. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23232-6 · Cited by 128
KCNQ4 channel activation by BMS-204352 and retigabine
Schrøder, R. L., Jespersen, T., Christophersen, P., Strøbæk, D., Jensen, B., & Olesen, S. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00029-6 · Cited by 123
Mechanism of Action of a Novel Human ether-a-go-go-Related Gene Channel Activator
Casis, Ó., Olesen, S., & Sanguinetti, M. C. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.019943 · Cited by 123
Kv7.1 (KCNQ1) properties and channelopathies
Péroz, D., Rodriguez, N., Choveau, F. S., Baró, I., Mérot, J., & Loussouarn, G. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2007.148254 · Cited by 122
Linley, J. E., Rose, K., Patil, M., Robertson, B., Akopian, A. N., & Gamper, N. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2297-08.2008 · Cited by 122
Xiong, Q., Sun, H., & Li, M. (2007) · Nature Chemical Biology · doi:10.1038/nchembio874 · Cited by 118
Expression and function of the K+channel KCNQ genes in human arteries
Ng, F. L., Davis, A. J., Jepps, T. A., Harhun, M. I., Yeung, S. Y., Wan, A., Reddy, M., Melville, D., Nardi, A., Khong, T. K., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01027.x · Cited by 117
Therapy development in Huntington disease: From current strategies to emerging opportunities
Dickey, A. S., & Spada, A. R. L. (2017) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.38494 · Cited by 117
Maljevic, S., Wuttke, T. V., Seebohm, G., & Lerche, H. (2010) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-010-0831-3 · Cited by 116
Synthesis and biological evaluation of the first pentafluorosulfanyl analogs of mefloquine
Wipf, P., Mo, T., Geib, S. J., Caridha, D. P., Dow, G. S., Gerena, L., Roncal, N. E., & Milner, E. (2009) · Organic & Biomolecular Chemistry · doi:10.1039/b911483a · Cited by 116
Self-citationDoan, T. N., & Kunze, D. L. (1999) · The Journal of Physiology · doi:10.1111/j.1469-7793.1999.125af.x · Cited by 115
Potassium channel genes and benign familial neonatal epilepsy
Maljevic, S., & Lerche, H. (2014) · Progress in brain research · doi:10.1016/b978-0-444-63326-2.00002-8 · Cited by 115
Ropinirole, a New ALS Drug Candidate Developed Using iPSCs
Okano, H., Yasuda, D., Fujimori, K., Morimoto, S., & Takahashi, S. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.12.002 · Cited by 111
KV7 potassium channels: a new therapeutic target in smooth muscle disorders
Stott, J. B., Jepps, T. A., & Greenwood, I. A. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.12.003 · Cited by 111
Kornhuber, J., Bleich, S., Wiltfang, J., Maler, M., & Parsons, C. G. (1999) · Journal of Neural Transmission · doi:10.1007/s007020050206 · Cited by 108
New insights into the causes and therapy of cerebral vasospasm following subarachnoid hemorrhage
Crowley, R. W., Medel, R., Kassell, N. F., & Dumont, A. S. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2007.11.010 · Cited by 106
Kalappa, B. I., Soh, H., Duignan, K. M., Furuya, T., Edwards, S., Tzingounis, A. V., & Tzounopoulos, T. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.5176-14.2015 · Cited by 105
Peptide hormone ghrelin enhances neuronal excitability by inhibition of Kv7/KCNQ channels
Shi, L., Bian, X., Qu, Z., Ma, Z., Zhou, Y., Wang, K., Jiang, H., & Xie, J. (2013) · Nature Communications · doi:10.1038/ncomms2439 · Cited by 103
Heel, R. C., Brogden, R. N., Speight, T. M., & Avery, G. S. (1977) · Drugs · doi:10.2165/00003495-197714050-00002 · Cited by 103
Current therapeutic landscape in multiple sclerosis: an evolving treatment paradigm
Cree, B., Mareš, J., & Hartung, H. (2019) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000700 · Cited by 103
Joshi, S. K., Hernandez, G., Mikusa, J. P., Zhu, C. Z., Zhong, C., Salyers, A. K., Wismer, C. T., Chandran, P., Decker, M. W., & Honoré, P. H. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.08.005 · Cited by 102
Mackie, A. R., & Byron, K. L. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.049825 · Cited by 102
Zaydman, M. A., Kasimova, M. A., McFarland, K., Beller, Z. W., Hou, P., Kinser, H. E., Liang, H., Zhang, G., Shi, J., Tarek, M., et al. (2014) · eLife · doi:10.7554/elife.03606 · Cited by 101
Pharmacological Activation of Normal and Arrhythmia-Associated Mutant KCNQ1 Potassium Channels
Seebohm, G., Pusch, M., Chen, J., & Sanguinetti, M. C. (2003) · Circulation Research · doi:10.1161/01.res.0000102866.67863.2b · Cited by 101
Ion Channels in Neurological Disorders
Kumar, P., Kumar, D., Jha, S. K., Jha, N. K., & Ambasta, R. K. (2015) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2015.10.006 · Cited by 98
Characterization of KCNQ5/Q3 potassium channels expressed in mammalian cells
Wickenden, A. D., Zou, A., Wagoner, P. K., & Jegla, T. J. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703861 · Cited by 97
Inhibition of I Ks channels by HMR 1556
Gögelein, H., Brüggemann, A., Gerlach, U., Brendel, J., & Busch, A. E. (2000) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002100000284 · Cited by 96
Voltage-gated K+ channel KCNQ1 regulates insulin secretion in MIN6 β-cell line
Yamagata, K., Senokuchi, T., Lu, M., Takemoto, M., Karim, M. F., Go, C., Sato, Y., Hatta, M., Yoshizawa, T., Araki, E., et al. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.03.083 · Cited by 96
Ma, D., Wei, H., Lu, J., Huang, D., Liu, Z., Loh, L. J., Islam, O., Liew, R., Shim, W., & Cook, S. A. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0027-z · Cited by 96
Al-Mousawi, A. H., Evans, N., Ebmeier, K. P., Roeda, D., Chaloner, F., & Ashcroft, G. W. (1996) · British Journal of Psychiatry · doi:10.1192/bjp.169.4.509 · Cited by 95
Genetic Mouse Models of Huntington’s Disease: Focus on Electrophysiological Mechanisms
Cepeda, C., Cummings, D. M., André, V. M., Holley, S. M., & Levine, M. S. (2010) · ASN Neuro · doi:10.1042/an20090058 · Cited by 93
The acrylamide (S)-1 differentially affects Kv7 (KCNQ) potassium channels
Bentzen, B. H., Schmitt, N., Calløe, K., Brown, W. D., Grunnet, M., & Olesen, S. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.07.001 · Cited by 93
Lerche, C. J., Bruhova, I., Lerche, H., Steinmeyer, K., Wei, A. D., Strutz‐Seebohm, N., Lang, F. J. W., Busch, A. E., Zhorov, B. S., & Seebohm, G. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.031682 · Cited by 92
Structural Basis for the Modulation of Human KCNQ4 by Small-Molecule Drugs
Li, T., Wu, K., Yue, Z., Wang, Y., Zhang, F., & Shen, H. (2021) · Molecular Cell · doi:10.1016/j.molcel.2020.10.037 · Cited by 92
Abitbol, I., Peretz, A., Lerche, C., Busch, A. E., & Attali, B. (1999) · The EMBO Journal · doi:10.1093/emboj/18.15.4137 · Cited by 92
Targeting the voltage sensor of Kv7.2 voltage-gated K + channels with a new gating-modifier
Peretz, A., Pell, L., Gofman, Y., Haitin, Y., Shamgar, L., Patrich, E., Kornilov, P., Gourgy-Hacohen, O., Ben-Tal, N., & Attali, B. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911294107 · Cited by 91
Effects of IKs channel inhibitors in insulin-secreting INS-1 cells
Ullrich, S., Su, J., Ranta, F., Wittekindt, O. H., Ris, F., Rösler, M., Gerlach, U., Heitzmann, D., Warth, R., & Lang, F. J. W. (2005) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-005-1479-2 · Cited by 91
Coordinated signal integration at the M‐type potassium channel upon muscarinic stimulation
Kosenko, A., Kang, S., Smith, I. M., Greene, D. L., Langeberg, L. K., Scott, J. D., & Hoshi, N. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.156 · Cited by 91
In Search of a Consensus Model of the Resting State of a Voltage-Sensing Domain
Vargas, E., Bezanilla, F., & Roux, B. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.024 · Cited by 90
Kardosh, A., Wang, W., Uddin, J., Petasis, N. A., Hofman, F. M., Chen, T. C., & Schönthal, A. H. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.5.1699 · Cited by 90
Atomic basis for therapeutic activation of neuronal potassium channels
Kim, R. Y., Yau, M. C., Galpin, J. D., Seebohm, G., Ahern, C. A., Pless, S. A., & Kurata, H. T. (2015) · Nature Communications · doi:10.1038/ncomms9116 · Cited by 89
Hernandez, C. C., Zaika, O., & Shapiro, M. S. (2008) · The Journal of General Physiology · doi:10.1085/jgp.200810007 · Cited by 89
Zaika, O., Lara, L. S., Gamper, N., Hilgemann, D. W., Jaffe, D. B., & Shapiro, M. S. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.114074 · Cited by 89
The KCNQ2/3 selective channel opener ICA-27243 binds to a novel voltage-sensor domain site
Padilla, K. M., Wickenden, A. D., Gerlach, A. C., & McCormack, K. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.08.071 · Cited by 88
HMR 1556, A Potent and Selective Blocker of Slowly Activating Delayed Rectifier Potassium Current
Thomas, G. P., Gerlach, U., & Antzelevitch, C. N. (2003) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200301000-00018 · Cited by 88
Nickolson, V. J., Tam, S. W., Myers, M. J., & Cook, L. (1990) · Drug Development Research · doi:10.1002/ddr.430190307 · Cited by 87
Do‐Ha, D., Buskila, Y., & Ooi, L. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0392-y · Cited by 84
Retigabine and flupirtine exert neuroprotective actions in organotypic hippocampal cultures
Boscia, F., Annunziato, L., & Taglialatela, M. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.03.024 · Cited by 82
Direct neurotransmitter activation of voltage-gated potassium channels
Manville, R. W., Papanikolaou, M., & Abbott, G. W. (2018) · Nature Communications · doi:10.1038/s41467-018-04266-w · Cited by 82
Hou, P., Eldstrom, J., Shi, J., Zhong, L., McFarland, K., Gao, Y., Fedida, D., & Cui, J. (2017) · Nature Communications · doi:10.1038/s41467-017-01911-8 · Cited by 81
Cuevas, J., Harper, A. A., Trequattrini, C., & Adams, D. J. (1997) · Journal of Neurophysiology · doi:10.1152/jn.1997.78.4.1890 · Cited by 80
Tan, A., Costi, S., Morris, L. S., Van Dam, N. T., Kautz, M., Whitton, A. E., Friedman, A. K., Collins, K. A., Ahle, G., Chadha, N., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-018-0283-2 · Cited by 80
Activation of KCNQ5 channels stably expressed in HEK293 cells by BMS-204352
Dupuis, D. S., Schrøder, R. L., Jespersen, T., Christensen, J. K., Christophersen, P., Jensen, B., & Olesen, S. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01287-6 · Cited by 79
Nattel, S., & Zeng, F. D. (1984) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21870-5 · Cited by 77
Kapetanović, I. M., Yonekawa, W. D., & Kupferberg, H. J. (1995) · Epilepsy Research · doi:10.1016/0920-1211(95)00050-x · Cited by 76
Design of nonpeptidal ligands for a peptide receptor: cholecystokinin antagonists
Evans, B., Rittle, K. E., Bock, M. G., DiPardo, R. M., Freidinger, R. M., Whitter, W. L., GOULD, N. P., Lundell, G. F., & Homnick, C. F. (1987) · Journal of Medicinal Chemistry · doi:10.1021/jm00390a019 · Cited by 75
The contribution of Kv7 channels to pregnant mouse and human myometrial contractility
McCallum, L. A., Pierce, S., England, S. K., Greenwood, I. A., & Tribe, R. M. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01021.x · Cited by 73
Mattmann, M. E., Yu, H., Lin, Z., Xu, K., Huang, X., Long, S., Wu, M., McManus, O. B., Engers, D. W., Le, U., et al. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.07.060 · Cited by 70
Bal, M., Zhang, J., Zaika, O., Hernandez, C. C., & Shapiro, M. S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805216200 · Cited by 70
Have there been improvements in Alzheimer’s disease drug discovery over the past 5 years?
Cacabelos, R. (2018) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1457645 · Cited by 70
Huang, H., Pugsley, M. K., Fermini, B., Curtis, M. J., Koerner, J. E., Accardi, M. V., & Authier, S. (2017) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2017.04.002 · Cited by 70
Flupirtine, a re-discovered drug, revisited
Szelenyi, I. (2013) · Inflammation Research · doi:10.1007/s00011-013-0592-5 · Cited by 69
Roeloffs, R., Wickenden, A. D., Crean, C. S., Werness, S., McNaughton-Smith, G. A., Stables, J. P., McNamara, J. O., Ghodadra, N., & Rigdon, G. C. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.137794 · Cited by 69
Jakob, R., & Krieglstein, J. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701519 · Cited by 69
Characterization of M-Current in Ventral Tegmental Area Dopamine Neurons
Koyama, S., & Appel, S. B. (2006) · Journal of Neurophysiology · doi:10.1152/jn.00574.2005 · Cited by 67
Gabapentin Is a Potent Activator of KCNQ3 and KCNQ5 Potassium Channels
Manville, R. W., & Abbott, G. W. (2018) · Molecular Pharmacology · doi:10.1124/mol.118.112953 · Cited by 67
New antiepileptic medication linked to blue discoloration of the skin and eyes
Clark, S., Antell, A., & Kaufman, K. (2015) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098614560736 · Cited by 66
M channel enhancers and physiological M channel block
Linley, J. E., Pettinger, L., Huang, D., & Gamper, N. L. (2011) · The Journal of Physiology · doi:10.1113/jphysiol.2011.223404 · Cited by 65
Synthesis and Evaluation of Potent KCNQ2/3-Specific Channel Activators
Kumar, M., Reed, N. L., Liu, R., Aizenman, E., Wipf, P., & Tzounopoulos, T. (2016) · Molecular Pharmacology · doi:10.1124/mol.115.103200 · Cited by 65
Self-citationMolecular impact of MinK on the enantiospecific block of IKs by chromanols
Lerche, C. J., Seebohm, G., Wagner, C. I., Scherer, C. R., Dehmelt, L., Abitbol, I., Gerlach, U. V., Brendel, J., Attali, B., & Busch, A. E. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703734 · Cited by 64
Molecular and functional characterization of Kv7 K+channel in murine gastrointestinal smooth muscles
Jepps, T. A., Greenwood, I. A., Moffatt, J. D., Sanders, K. M., & Ohya, S. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00057.2009 · Cited by 64
Yu, H., Wu, M., Townsend, S. D., Zou, B., Long, S., Daniels, J. S., McManus, O. B., Li, M., Lindsley, C. W., & Hopkins, C. R. (2011) · ACS Chemical Neuroscience · doi:10.1021/cn200065b · Cited by 64
Functional effects of the KCNQ modulators retigabine and XE991 in the rat urinary bladder
Rode, F., Svalø, J., Sheykhzade, M., & Rønn, L. C. B. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.03.050 · Cited by 64
Chang, X., Wang, J., Jiang, H., Shi, L., & Xie, J. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00141 · Cited by 63
Brueggemann, L. I., Mackie, A. R., Martin, J. W., Cribbs, L. L., & Byron, K. L. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.067496 · Cited by 63
Abd-Elsayed, A. A., Jackson, M., Gu, S. L., Fiala, K. J., & Gu, J. (2019) · Molecular Pain · doi:10.1177/1744806919864256 · Cited by 63
Alteration of GABA ergic neurotransmission in Huntington's disease
Garret, M., Du, Z., Chazalon, M., Cho, Y. H., & Baufreton, J. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12826 · Cited by 62
Groseclose, M. R., & Castellino, S. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.8b00313 · Cited by 62
Potassium Channels: A Potential Therapeutic Target for Parkinson’s Disease
Chen, X., Xue, B., Wang, J., Liu, H., Shi, L., & Xie, J. (2017) · Neuroscience Bulletin · doi:10.1007/s12264-017-0177-3 · Cited by 61
A Randomized, Controlled Trial of Linopirdine in the Treatment of Alzheimer's Disease
Rockwood, K., Beattie, B. L., Eastwood, M. R., Feldman, H., Mohr, E., Pryse-Phillips, W., & Gauthier, S. (1997) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s031716710002148x · Cited by 60
Gao, Z., Zhang, T., Wu, M., Xiong, Q., Sun, H., Zhang, Y., Zu, L., Wang, W., & Li, M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.116392 · Cited by 60
Bauer, A., Becker, R., Freigang, K. D., Senges, J. C., Voss, F., Hansen, A., Müller, M., Lang, H. J., Gerlach, U., Busch, A. E., et al. (1999) · Circulation · doi:10.1161/01.cir.100.21.2184 · Cited by 60
Wu, Y., Davis, C. D., Dworetzky, S. I., Fitzpatrick, W., Harden, D., He, H., Knox, R. J., Newton, A. E., Philip, T., Polson, C. T., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm034111v · Cited by 60
Abd-Elsayed, A. A., Ikeda, R., Jia, Z., Ling, J., Zuo, X., Li, M., & Gu, J. G. (2015) · Molecular Pain · doi:10.1186/s12990-015-0048-8 · Cited by 59
The Voltage Activation of Cortical KCNQ Channels Depends on Global PIP2 Levels
Kim, K. S., Duignan, K. M., Hawryluk, J. M., Soh, H., & Tzingounis, A. V. (2016) · Biophysical Journal · doi:10.1016/j.bpj.2016.01.006 · Cited by 59
Mode of antinociceptive action of flupirtine in the rat
Szelenyi, I., Nickel, B., Borbe, H. O., & Brune, K. (1989) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1989.tb12023.x · Cited by 58
Synthesis and Activity of Novel and Selective IKs-Channel Blockers
Gerlach, U., Brendel, J., Lang, H., Paulus, E. F., Weidmann, K., Brüggemann, A., Busch, A. E., Suessbrich, H., Bleich, M., & Greger, R. F. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm0109255 · Cited by 58
Suessbrich, H., Bleich, M., Ecke, D., Rizzo, M., Waldegger, S., Lang, F. J. W., Szabó, I., Lang, H. J., Kunzelmann, K., Greger, R. F., et al. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)01113-1 · Cited by 58
Morimoto, S., Takahashi, S., Fukushima, K., Saya, H., Suzuki, N., Aoki, M., Okano, H., & Nakahara, J. (2019) · Regenerative Therapy · doi:10.1016/j.reth.2019.07.002 · Cited by 58
Brueggemann, L. I., Kakad, P. P., Love, R. B., Solway, J., Dowell, M. L., Cribbs, L. L., & Byron, K. L. (2012) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00194.2011 · Cited by 57
The gating charge pathway of an epilepsy-associated potassium channel accommodates chemical ligands
Li, P., Chen, Z., Xu, H., Sun, H., Li, H., Liu, H., Yang, H., Gao, Z., Jiang, H., & Li, M. (2013) · Cell Research · doi:10.1038/cr.2013.82 · Cited by 56
Gilling, M., Rasmussen, H. B., Calloe, K., Sequeira, A. F., Baretto, M., Oliveira, G., Almeida, J., Lauritsen, M. B., Ullmann, R., Boonen, S. E., et al. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00054 · Cited by 56
Potassium Channel Blockers and Openers as CNS Neurologic Therapeutic Agents
Judge, S. I. V., Smith, P. J., Stewart, P., & Bever, C. T. (2007) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488907782411765 · Cited by 55
Wu, Y.-J., Boissard, C. G., Greco, C., Gribkoff, V. K., Harden, D. G., He, H., L'Heureux, A., Kang, S. H., Kinney, G. G., Knox, R. J., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm034073f · Cited by 54
Hughes, S. A., Marsh, S. J., Tinker, A., & Brown, D. A. (2007) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-007-0259-6 · Cited by 53
Castro‐Alamancos, M. A., Rigas, P., & Tawara‐Hirata, Y. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2006.119016 · Cited by 53
Research works printed but not linked: 24
- Dorange, 2011, Annu. Rep. Med. Chem., 46, 53
- Brueggemann, 2012, Am. J. Physiol., 302, 120
- Jepps, 2009, Am. J. Physiol., 297, 107
- Herrmann, 1987, Postgrad. Med. J., 63, 87
- Barrese, 2010, Clin. Pharmacol., 2, 225
- H. Yu , Z.Lin , K.Xu , X.Huang , S.Long , M.Wu , O. B.McManus , J.Le Engers , M. E.Mattmann , D. W.Engers , U. M.Le , C. W.Lindsley , C. R.Hopkins and M.Li , Probe Reports from the NIH Molecular Libraries Program [Internet] , 2013
- Wickenden, 2000, Mol. Pharmacol., 58, 591, 10.1124/mol.58.3.591 · doi:10.1124/mol.58.3.591 · Paper page
- Zilliox, 2017, Continuum, 23, 512
- Atri, 2019, J. Clin. Psychiatry, 80, MS18002AH3C
- Repovic, 2019, Continuum, 25, 655
- Sheppard, 2014, Acta Otorhinolaryngol. Ital., 34, 79
- Shin, 2019, Hum. Mutat., 40, 335
- Su, 2012, Evid. Based Complement. Alternat. Med., 2012, 803082
- Xu, 2002, Am. J. Physiol., 283, 664
- Dalby-Brown, 2013, Eur. J. Pharmacol., 709, 52, 10.1016/j.ejphar.2013.03.039 · DOI
- D. E. Furst and T.Munster , in Nonsteroidal ant-inflammatory drugs, disease modifying antirheumatic drugs, nonopioid analgesics and drugs used in gout , ed. B. G. Katzung , McGraw-Hill Book Company , New York , 2001 , pp. 596–623
- Liu, 2014, Zhongguo Yaolixue Tongbao, 30, 574
- Ma, 2014, J. Chin. Pharm. Sci., 23, 153
- Kim, 2015, Nat. Commun., 6, 8116, 10.1038/ncomms9116 · DOI · Paper page
- Bett, 2006, J. Physiol., 576, 755, 10.1113/jphysiol.2006.116012 · DOI
- Zaczek, 1998, J. Pharmacol. Exp. Ther., 285, 724
- Yang, 2000, J. Pharmacol. Exp. Ther., 294, 955
- Zeng, 2019, JRSM Cardiovasc. Dis., 8, 2048004019854919
- Nattel, 1984, J. Pharmacol. Exp. Ther., 229, 283
Cited by
A small-molecule activation mechanism that directly opens the KCNQ2 channel
Zhang, S.-Y., Ma, D., Wang, K., Li, Y., Yang, Z., Li, X., Li, J., He, J., Mei, L., Ye, Y., et al. (2024) · Nature Chemical Biology · doi:10.1038/s41589-023-01515-y · Cited by 32
“Efforts have been dedicated to identifying small molecules that enhance KCNQ2 currents, particularly at subthreshold voltages, in which increased KCNQ2 activity can effectively prevent abnormal or excessive neuronal firing 21,22 .”
Yan, Z., Zhong, L., Zhu, W., Chung, S. K., & Hou, P. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106765 · Cited by 33
Recent advances in the pharmacology of voltage-gated ion channels
Mateos, D. L., Harris, B. J., Hernández-González, A., Yarov-Yarovoy, V. M., & Wulff, H. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100090 · Cited by 31
Pinheiro, B. P., Müller, M. C., Bös, M., Guezguez, J., Burnet, M. W. M., Tornincasa, M., Rizzetto, R., Rolland, J., Liberati, C., Lohmer, S., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04915-5 · Cited by 21
Henton, A., Zhao, Y., & Tzounopoulos, T. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.1070-22.2023 · Cited by 15
“KCNQ channels have been a successful target for drug development (Davoren et al., 2015; Manville and Abbott, 2018; Miceli et al., 2018; Seefeld et al., 2018; Ostacolo et al., 2020; Borgini et al., 2021).”
Background
Metadata
- Authors
- Borgini, M., Mondal, P., Liu, R., & Wipf, P.
- Affiliations
- University of Pittsburgh (US)
- Corresponding author
- Wipf, Peter
- Venue
- RSC Medicinal Chemistry
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2021
- Volume
- 12
- Issue
- 4
- Pages
- 483-537
- ISSN
- 2632-8682 (ISSN-L)
- PMC
- PMC8128042
- OpenAlex
- W3119057473
- Cited by
- 37
- References
- 386
- Citations by year
- 2026: 6 · 2025: 8 · 2024: 7 · 2023: 5 · 2022: 10 · 2021: 1
- FWCI
- 0.63
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- RSC Medicinal Chemistry (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Defense (W81XWH1810623)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Physical Sciences › Chemistry › Organic Chemistry › Heterocyclic Compound Synthesis and Bioactivity
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- Kv7 potassium channels, KCNQ channels, voltage-gated potassium channels, small molecule modulators, channel blockers, synthetic chemistry, medicinal chemistry, clinical properties
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.